Research on Stevioside in China Market Share, Growth, Size, Trends and Forecast 2017 - 2022

Stevioside is the main sweetener with rebaudioside A, found in the leaves of Stevia rebaudiana, a plant originating in South America. Dried leaf, as well as aqueous extracts, has been used for decades as a sweetener in many countries, “Research on Stevioside in China Market” notably in Latin America and Asia (Japan, China). Especially in Asia, South America and the US, stevioside is largely used in food manufacturing. In 2016, about 3,000 kinds of products containing stevioside were newly introduced.

Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1322066

Although stevioside has a long history in South America, China is the major producer, taking 90% of the global capacity, making it the largest planter of stevia rebaudiana, the largest producer and exporter of stevioside. More than 70% of stevioside produced in China is exported, which means overseas demand has bigger influence on the countrys output. In 2016, the output of stevioside in the country reached nearly 8,000 tonnes.

In the future, stevioside will be affected by per capita consumption of zero-calorie beverages and new stevioside products costing less and benefitting peoples health. Emerging markets and developing regions create opportunities for investors. Because stevioside has a zero glycemic index and zero calorie, it is popular in many countries.

In recent years, stevioside has replaced some other sweeteners in food, medicine and daily chemical industries, driving continuously rising demand for the sweetener and providing more space for leading enterprises in the industry. At the same time, along with the downstream s development, the demand for high-purity stevioside will increase as well, which brings new profits to manufacturers with innovative ability. In 2022, sales volume of stevioside is forecasted to reach about 4,000 tonnes and the market scale will be around RMB3.4 billion.
Executive Summary
Methodology

Browse Full Report With TOC - http://www.marketresearchhub.com/report/market-research-on-stevioside-in-china-2017-2022-report.html

1 Development Environment for Stevioside Industry in China
1.1 Economy
1.2 Policy
1.3 General Development Analysis of Plant Extracts in China
2 General Status of China Stevioside Market, 2012-2016
2.1 Supply
2.1.1 Capacity
2.1.2 Output
2.2 Market Scale
2.3 Demand
2.4 Price
2.5 Export

3 Industrial Chain of Stevioside in China
3.1 Planting Area of Stevia Rebaudiana
3.2 Downstream
4 Analysis of Key Stevioside Enterprises in China
4.1 PureCircle (Jiangxi) Co. Ltd.
4.2 Zhucheng Haotian Pharm Co., Ltd.
4.3 Qufu Lvtianyuan High Technology Co., Ltd
4.4 Biolotus Technology Jiangsu Inc.
4.5 Chenguang Biotech Group Co., Ltd.

5 Forecast and Investment Suggestions of Stevioside Industry in China, 2017-2022
5.1 Forecast
5.2 Investment Suggestion
5.2.1 Meaning of Strategy Planning
5.2.2 Principles of Strategy Planning
5.2.3 Analysis on Strategy Planning
5.2.4 Key Customer Strategy
Continue….

Enquire About this Report - http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1322066

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:

90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email : press@marketresearchhub.com
Website : http://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.